Compare Aurora Cannabis Inc (ACB) vs Sanofi SA (SNY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs Sanofi SA — how do they compare? Aurora Cannabis Inc trades at $2.7 (market cap $165.36M), while Sanofi SA trades at $42.85 (market cap $103.29B). The key difference: Sanofi SA is far larger — about 624.6× Aurora Cannabis Inc's market cap, and Sanofi SA pays a 5.63% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | SNY | |
|---|---|---|
Market Cap | $165.36M | $103.29B |
Sector | Health | Health |
52-Week High | $6.23 | $52.34 |
52-Week Low | $2.67 | $41.33 |
Enterprise Value | $99.82M | $119.78B |
Dividend Yield | — | 5.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
